Effect of synthetic thyrotropin-releasing factor (TRF) on pituitary TSH secretion in man.
D000238:Adenoma, Chromophobe / Q000378:metabolism; D000305:Adrenal Cortex Hormones / Q000652:urine; D000328:Adult; D000368:Aged; D001798:Blood Proteins / Q000032:analysis; D002277:Carcinoma / Q000378:metabolism; D003397:Craniopharyngioma / Q000378:metabolism; D004700:Endocrine System Diseases / Q000378:metabolism; D005260:Female; D006801:Humans; D007018:Hypopituitarism / Q000378:metabolism; D007275:Injections, Intravenous; D007455:Iodine / Q000097:blood; D008297:Male; D009325:Nausea / Q000139:chemically induced; D010455:Peptides / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D010911:Pituitary Neoplasms / Q000378:metabolism; D011485:Protein Binding; D013268:Stimulation, Chemical; D013972:Thyrotropin / Q000097:blood / Q000378:metabolism*; D013973:Thyrotropin-Releasing Hormone / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D014284:Triiodothyronine / Q000097:blood
D000305:Adrenal Cortex Hormones; D001798:Blood Proteins; D010455:Peptides; D014284:Triiodothyronine; D013973:Thyrotropin-Releasing Hormone; D013972:Thyrotropin; D007455:Iodine